Role of radiotherapy in patients with early-stage diffuse large B-cell lymphoma of Waldeyer's ring in remission after anthracycline-containing chemotherapy

Leukemia and Lymphoma

Volumn 54, Issue 1, 2013, Pages 62-68

  Mian, Michael ^a   Ferreri, Andrés J M ^b   Rossi, Andrea ^c   Conconi, Annarita ^d   Tsang, Richard ^e   Gospodarowicz, Mary K ^e   Oldani, Elena ^c   Federico, Massimo ^f   Luminari, Stefano ^f   Pogliani, Enrico M ^g   Rossini, Fausto ^g   Cabrera, Maria E ^h   Martelli, Maurizio ⁱ   Gutierrez Garcia, Gonzalo ^j   Busetto, Mario ^k   Cavalli, Franco ^l   Zucca, Emanuele ^l   Rambaldi, Alessandro ^c   Cortelazzo, Sergio ^a  

^a Azienda Ospedaliera S Maurizio   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c OSPEDALI RIUNITI   (Italy)

^d UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^e PRINCESS MARGARET HOSPITAL   (Canada)

^f UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^g UNIVERSITY OF MILANO BICOCCA   (Italy)

^h UNIVERSITY OF CHILE   (Chile)

ⁱ SAPIENZA UNIVERSITY OF ROME   (Italy)

^j HOSPITAL CLÍNIC   (Spain)

^k OSPEDALE DELL'ANGELO   (Italy)

^l REGIONAL HOSPITAL OF LUGANO   (Switzerland)

more..

Author keywords

Chemotherapy; DLBCL; Lymphoma; Radiotherapy; Waldeyer

Indexed keywords

RITUXIMAB;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONSOLIDATION RADIOTHERAPY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TUMOR REGRESSION; WALDEYER RING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTHRACYCLINES; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAUSE OF DEATH; FEMALE; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; RECURRENCE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84870950629     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2012.710907     Document Type: Article

References (22)

1. Hoppe RT, Burke JS, Glatstein E, et al. Non-Hodgkin's lymphoma: Involvement of Waldeyer's ring. Cancer 1978; 42: 1096- 1104. (Pubitemid 9054564)
2. Yuen A, Jacobs C. Lymphomas of the head and neck. Semin Oncol 1999 ; 26: 338-345. (Pubitemid 29272901)
3. Banfi A, Bonadonna G, Ricci SB, et al. Malignant lymphomas of Waldeyer's ring: Natural history and survival after radiotherapy. Br Med J 1972 ; 3: 140-143.
4. Aviles A, Delgado S, Ruiz H, et al. Treatment of non-Hodgkin's lymphoma of Waldeyer's ring: Radiotherapy versus chemotherapy versus combined therapy. Eur J Cancer B Oral Oncol 1996 ; 32B: 19-23.
5. Laskar S, Mohindra P, Gupta S, et al. Non-Hodgkin lymphoma of the Waldeyer's ring: Clinicopathologic and therapeutic issues. Leuk Lymphoma 2008; 49: 2263- 2271.
6. L askar S, B ahl G, M uckaden M A, et al. P rimary diff use large B-cell lymphoma of the tonsil: Is a higher radiotherapy dose required? Cancer 2007 ; 110: 816-823. (Pubitemid 47257659)
7. C hang D T, M endenhall N P, L ynch J W, et al. L ong-term outcomes for stage I-II aggressive non-Hodgkin lymphoma of Waldeyer's ring. Am J Clin Oncol 2009 ; 32: 233-237.
8. Ezzat AA, Ibrahim EM, El Weshi AN, et al. Localized non-Hodgkin's lymphoma of Waldeyer's ring: Clinical features, mana gement, and prognosis of 130 adult patients. Head Neck 2001 ; 23: 547-558. (Pubitemid 32565528)
9. Saul SH, Kapadia SB. Primary lymphoma of Waldeyer's ring. Clinicopathologic study of 68 cases. Cancer 1985 ; 56 :157-166. (Pubitemid 15022865)
10. Chang DT, Amdur RJ, Pacholke H, et al. Xerostomia in longterm survivors of aggressive non-Hodgkin' s lymphoma of Waldeyer's ring: A potential role for parotid-sparing techniques? Am J Clin Oncol 2009 ; 32: 145-149.
11. Carbone PP, Kaplan HS, Musshoff K, et al. Report of the Committee on Hodgkin's Disease Staging Classifi cation. Cancer Res 1971; 31: 1860-1861.
12. Jaff e E, Harris N, Stein H, et al. Pathology and genetics of tumors of haematopoietic and lymphoid tissues. Lyon: World Health Organization; 2001.
13. Cheson BD, Pfi stner B, Juweid ME, et al. Revised response criteria for malignant lymphoma. J Clin Oncol 2007 ; 25: 579-586. (Pubitemid 350002966)
14. Cox DR. Regression models and life-tables. J R Stat Soc B 1972 ; 34: 187-220.
15. Miller TP, Dahlberg S, Cassady JR, et al. Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma. N Engl J Med 1998 ; 339: 21-26. (Pubitemid 28304493)
16. Lopez-Guillermo A, Colomo L, Jimenez M, et al. Diff use large B-cell lymphoma: Clinical and biological characterization and outcome according to the nodal or extranodal primary origin. J Clin Oncol 2005 ; 23: 2797-2804. (Pubitemid 46179470)
17. Gutierrez-Garcia G, Colomo L, Villamor N, et al. Clinico-biological characterization and outcome of primary nodal and extranodal diff use large B-cell lymphoma in the rituximab era. Leuk Lymphoma 2010 ; 51: 1225-1232.
18. Persky DO, Unger JM, Spier CM, et al. Phase II study of rituximab plus three cycles of CHOP and involved-field radio therapy for patients with limited-stage aggressive B-cell lymphoma: Southwest Oncology Group study 0014. J Clin Oncol 2008 ; 26: 2258-2263.
19. Bonnet C, Fillet G, Mounier N, et al. CHOP alone compared with CHOP plus radiotherapy for localized aggressive lymphoma in elderly patients: A study by the Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol 2007 ; 25: 787-792. (Pubitemid 350002878)
20. R eyes F, L epage E, G anem G, et al. A CVBP versus CHOP plus radiotherapy for localized aggressive lymphoma. N Engl J Med 2005 ; 352: 1197-1205. (Pubitemid 40397261)
21. Paes FM, Kalkanis DG, Sideras PA, et al. FDG PET/CT of extranodal involvement in non-Hodgkin lymphoma and Hodgkin disease. Radiographics 2010; 30: 269- 291.
22. Qi SN, Li YX, Wang H, et al. Diff use large B-cell lymphoma: Clinical characterization and prognosis of Waldeyer ring versus lymph node presentation. Cancer 2009 ; 115: 4980-4989.